HSE ebulletin containing informationon regulating biocides in Northern Ireland

Having trouble viewing this email?View the content as a web page.

HSE Header logo small

HSE ebulletin

New EU active substance non-approval decisions

Biocidal products must be phased off the NI market

Following withdrawal of support under the EU BPR, a decision has been taken not to approve the following active substance/product type combinations.

This will affect NI:

Biocidal products containing these active substances in the relevant product types can no longer be:

  • supplied in NI after 14 December 2023; or
  • used in NI after 14 June 2024

You must manage your stocks of the affected products to ensure they are removed from the NI supply chain by 14 December 2023.

New treated articles containing these active substances in the relevant product types cannot be entered into the supply chain or imported into NI after 12 June 2023. Treated articles that have entered NI supply chains before this date can continue to be supplied and used.

Find out more about treated articles.

Any affected NI product approvals under the Control of Pesticides Regulations (COPR) will be revoked in line with the above dates.

If you are aware of any disproportionate negative effects that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.


Reminder: upcoming EU active substance expiry dates

Biocidal products must be phased off the NI market

The active substance/product type combination listed below is due to expire under the EU BPR on the following date.

This affects NI:

  • Abamectin as a mixture of avermectin B1a (EINECS 265-610-3) and avermectin B1b (EINECS 265-611-9) (CAS 71751-41-2 EC n/a) in product type 18
    30 June 2023

Once the approval expires, the active substance can no longer be used in biocidal products of the relevant product types in NI.

If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.

If you are aware of any disproportionate negative effects that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us.

Get latest news and updates from HSE across a range of industries and topics bysubscribing to our ebulletins

GovUK footer logo

Health and Safety Executive - 5N1 Redgrave Court, Merton Road, Bootle, Merseyside L20 7HS